Focus 22 April 2014

Hot Minireviews

See what scientists world-wide are reading! View the most popular minireviews published in BJC.

Content

Immune modulation for cancer therapy
- J Naidoo
- D B Page
- J D Wolchok
Mini ReviewOpen Access11 Sep 2014 British Journal of Cancer
Oncogenic KRAS signalling in pancreatic cancer
- S Eser
- A Schnieke
- D Saur
Mini ReviewOpen Access22 Apr 2014 British Journal of Cancer
Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
- B Homet Moreno
- A Ribas
Mini ReviewOpen Access9 Apr 2015 British Journal of Cancer
Mitochondrial apoptosis: killing cancer using the enemy within
- J Lopez
- S W G Tait
Mini ReviewOpen Access5 Mar 2015 British Journal of Cancer
Beyond BRAF: where next for melanoma therapy?
- I V Fedorenko
- G T Gibney
- K S M Smalley
Mini ReviewOpen Access2 Sep 2014 British Journal of Cancer
Stem cells from adipose tissue and breast cancer: hype, risks and hope
- F Bertolini
- J-Y Petit
- M G Kolonin
Mini ReviewOpen Access13 Jan 2015 British Journal of Cancer
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
- M Pichler
- G A Calin
Mini ReviewOpen Access9 Jul 2015 British Journal of Cancer
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
- S J Thomas
- J A Snowden
- S J Danson
Mini ReviewOpen Access7 Jul 2015 British Journal of Cancer
The genomic evolution of human prostate cancer
- T Mitchell
- D E Neal
Mini ReviewOpen Access30 Jun 2015 British Journal of Cancer
Stem vs non-stem cell origin of colorectal cancer
- D J Huels
- O J Sansom
Mini ReviewOpen Access25 Jun 2015 British Journal of Cancer
Clinical utility of RASSF1A methylation in human malignancies
- A M Grawenda
- E O'Neill
ReviewOpen Access9 Jul 2015 British Journal of Cancer
Hallmarks of cancer stem cell metabolism
- Patricia Sancho
- David Barneda
- Christopher Heeschen
Mini ReviewOpen Access24 May 2016 British Journal of Cancer
Context-dependent effects of cellular senescence in cancer development
- Pacome Lecot
- Fatouma Alimirah
- Christopher Wiley
Mini ReviewOpen Access3 May 2016 British Journal of Cancer
Antibody-drug conjugates—an emerging class of cancer treatment
- Nikolaos Diamantis
- Udai Banerji
Mini ReviewOpen Access7 Jan 2016 British Journal of Cancer
Targeting cell death signalling in cancer: minimising ‘Collateral damage’
- Joanna L Fox
- Marion MacFarlane
Mini ReviewOpen Access3 May 2016 British Journal of Cancer
Metabolic scavenging by cancer cells: when the going gets tough, the tough keep eating
- Evdokia Michalopoulou
- Vinay Bulusu
- Jurre J Kamphorst
Mini ReviewOpen Access18 Aug 2016 British Journal of Cancer
From obesity to diabetes and cancer: epidemiological links and role of therapies
- Custodia García-Jiménez
- María Gutiérrez-Salmerón
- Antonio De la Vieja
Mini ReviewOpen Access23 Feb 2016 British Journal of Cancer

Hot Minireviews

Content

Immune modulation for cancer therapy

Oncogenic KRAS signalling in pancreatic cancer

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers

Mitochondrial apoptosis: killing cancer using the enemy within

Beyond BRAF: where next for melanoma therapy?

Stem cells from adipose tissue and breast cancer: hype, risks and hope

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours

The genomic evolution of human prostate cancer

Stem vs non-stem cell origin of colorectal cancer

Clinical utility of RASSF1A methylation in human malignancies

Hallmarks of cancer stem cell metabolism

Context-dependent effects of cellular senescence in cancer development

Antibody-drug conjugates—an emerging class of cancer treatment

Targeting cell death signalling in cancer: minimising ‘Collateral damage’

Metabolic scavenging by cancer cells: when the going gets tough, the tough keep eating

From obesity to diabetes and cancer: epidemiological links and role of therapies

Search

Quick links